Following the completion of its mandatory tender offer, Asia’s largest multinational private healthcare provider is doubling down on long-term value creation in India, advancing innovation and elevating operational excellence across its Fortis and Gleneagles hospital networks.
IHH Healthcare, Asia’s largest and leading multinational healthcare provider, today announced plans to accelerate expansion, deepen operational efficiencies and drive innovation across its India hospital network, following the successful closure of the open offer for Fortis Healthcare Limited and Fortis Malar Hospitals Limited. IHH’s shareholding in Fortis now stands at 31.17 per cent and 62.73 per cent in Malar.
“India is a key strategic growth market for IHH, and the successful completion of the open offer allows us to further strengthen our commitment to building world-class, patient-centric healthcare across the country,” said Prem Kumar Nair, Group Chief Executive Officer, IHH Healthcare. “By leveraging the combined strengths of the Fortis and Gleneagles networks, we aim to enhance access, quality and capacity in a sustainable way over the coming years.”
India remains one of the key growth markets where IHH is scaling strategically to establish world-class hospitals and elevate care delivery for patients across the country. Harnessing enhanced operational scale, clinical excellence and geographical reach across a combined network of 35 hospitals and over 5,000 beds spanning 11 states, IHH is leveraging operational and financial synergies to fuel its goal of adding approximately 2,000 new beds in India by 2028.
IHH is recognised internationally for operating some of the world’s most trusted healthcare brands including Acibadem, Gleneagles, Fortis, Island, Mount Elizabeth, Pantai, Parkway and Prince Court. It is one of the world’s most diversified healthcare groups, with a presence in 10 countries including Malaysia, Singapore, Turkiye, India and Greater China. In August this year, IHH refreshed its brand identity to reflect its ambition to be a global healthcare leader, shaping the future of care by driving meaningful innovation, strategic partnerships and powerful synergies across the healthcare ecosystem.
